41 – 50 of 130
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Clinical impact of intraprocedural stent thrombosis during percutaneous coronary intervention in patients treated with potent p2y12 inhibitors -A validate-swedeheart substudy
- Contribution to journal › Article
-
Mark
The association of mode of location activity and mobility with acute coronary syndrome : a nationwide ecological study
- Contribution to journal › Article
-
Mark
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
- Contribution to journal › Article
-
Mark
Assessing the external validity of the VALIDATE-SWEDEHEART trial
- Contribution to journal › Article
- 2020
-
Mark
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction : A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
- Contribution to journal › Article
-
Mark
Effect of Oxygen Therapy on Cardiovascular Outcomes in Relation to Baseline Oxygen Saturation
- Contribution to journal › Article
-
Mark
Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction : a VALIDATE-SWEDEHEART substudy
- Contribution to journal › Article
-
Mark
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery : 20-Year Follow-up of the Randomized SweBCGRT Trial
- Contribution to journal › Article
-
Mark
Apoptosis of hematopoietic progenitor-derived adipose tissue-resident macrophages contributes to insulin resistance after myocardial infarction
- Contribution to journal › Article
-
Mark
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
- Contribution to journal › Article
